Previous 10 | Next 10 |
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company entered into an amended and restated products purchase ag...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company's President and CEO, Dr. Mark Strobeck , will present...
2023-08-23 05:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-17 08:35:46 ET Summary Rockwell Medical's focus on the drug Triferic has led to neglect of its core operations in the hemodialysis concentrate business. The company is seeking to expand sales and improve profitability by focusing on the West states and its largest customer...
2023-08-16 13:38:03 ET Gainers: EBET ( EBET ) +160% . Novo Integrated Sciences ( NVOS ) +71% . Tivic Health Systems ( TIVC ) +58% . WeTrade Group ( WETG ) +43%. DLocal Limited ( DLO ) +35% . JX Luxventure Limited ( JXJT )...
2023-08-16 10:08:58 ET Gainers: Novo Integrated Sciences ( NVOS ) +86% . Aeon Biopharma ( AEON ) +11% . Biophytis ( BPTS ) +10% . Syros Pharmaceuticals ( SYRS ) +9% . MediciNova ( MNOV ) +8% . Losers: Impel Pharmaceuticals...
2023-08-14 10:20:24 ET Rockwell Medical, Inc. (RMTI) Q2 2023 Earnings Conference Call August 14, 2023, 8:00 AM ET Company Participants Heather Hunter - Senior Vice President and Chief Corporate Affairs Officer Mark Strobeck - President and Chief Executive Officer ...
2023-08-14 06:06:13 ET Rockwell Medical press release ( NASDAQ: RMTI ): Q2 GAAP EPS of -$0.18 misses by $0.06 . Revenue of $18.1M (-3.1% Y/Y) beats by $0.02M . Cash and cash equivalents and investments available-for-sale at June 30, 2023 was $14.9 million compa...
Net sales for the six months ended June 30, 2023 was $37.7 million, an 8% increase over $34.8 million for the same period in 2022. Gross profit for the six months ended June 30, 2023 was $3.6 million, a 260% increase over $1.0 million for the same period in 2022. Gross margin for the ...
2023-08-13 15:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...